Your success is our objective

Leads to Development’s international team of expert drug developers will work with you as an extension of your own team. As your partner, we collaborate with you at every step to ensure success throughout the stages of the lead’s development lifecycle.

We have managed 160+ nonclinical development programmes.

We have a 100% track record in obtaining clinical trial authorisations.

A number of projects we have managed have been successfully out-licensed at various development stages, most recently for >900M$

After having used our services, many clients have come back for follow-on or new projects.

Our regulatory and operational expertise is extensive


The benefits of working with
Leads To Development

How we work mobile view

Our expertise covers most product types in a wide range of medical indications

Product types

Therapeutic areas

Small molecule new chemical entities (NCEs)
Product types img antibody drug conjugate
Antibodies and antibody-drug conjugates (ADCs)
Product types img Viruses, bacteria
Product types img Proteins
Nucleic acids
Product types img Nucleic acids
Viruses, bacteria (including genetically modified organisms (GMOs))
Product types img Gene, cell and tissue therapies
Gene, cell and tissue therapies (advanced therapy medicinal products (ATMPs))
Implantable medical devices (MDs)
Implantable medical devices (MDs)

Therapeutic areas

Therapeutic area Oncology
Neurology and pain management
Neurology and pain management
Therapeutic area img Immunology
Immunology, auto-immune and inflammatory diseases
Therapeutic area img metabolic diseases
Endocrine and metabolic diseases
Therapeutic area img Cardiovascular indications
Cardiovascular indications
Therapeutic area img Infectious and parasitic diseases
Infectious and parasitic diseases
Ophthalmology and ear diseases
Ophthalmology and ear diseases
Therapeutic area img bone diseases
Orthopaedics and bone diseases


"As a US-based biopharmaceutical corporation, leveraging the resources of an EU-based experienced consultancy firm was critical for operational management and regulatory support of our ex-US studies."
Francisco Leon, Chief Scientific Officer, Provention Bio

"We have really benefited from tapping into L2D preclinical development expertise, which has allowed us to reach clinical milestones much more efficiently."
Karine Chorro, Chief Executive Officer, Phost'In Therapeutics

"LeadsToDevelopment provided us with operational support beyond our expectations in preclinical development, regulatory submission and production. Ultimately, LeadsToDevelopment has been key in the approval of the clinical trial application. Glad to have you on board for this adventure!"
Pascal Benderitter, Senior Program Director, Oncodesign

"We have really benefited from the CMC expertise that L2D has brought to our projects."
Cécile Bougeret, Vice President Operations, Diaccurate

Fruitful collaborations

A few of the leading companies we work with.